Neuropharmacological effects of the main phytocannabinoids: a narrative review (2020)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1007/978-3-030-57369-0_3
- Subjects: CANABINOIDES; RECEPTORES DE SEROTONINA; NEUROFARMACOLOGIA
- Keywords: Cannabinoids; Endocannabinoids; Mechanisms of action; Neuropharmacology; Phytocannabinoids
- Language: Inglês
- Imprenta:
- Source:
- Título: Cannabinoids and neuropsychiatric disorders
- Volume/Número/Paginação/Ano: 153 p
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SANTOS, Rafael Guimarães dos e HALLAK, Jaime Eduardo Cecilio e CRIPPA, José Alexandre de Souza. Neuropharmacological effects of the main phytocannabinoids: a narrative review. Cannabinoids and neuropsychiatric disorders. Tradução . Cham: Springer, 2020. . Disponível em: https://doi.org/10.1007/978-3-030-57369-0_3. Acesso em: 28 abr. 2025. -
APA
Santos, R. G. dos, Hallak, J. E. C., & Crippa, J. A. de S. (2020). Neuropharmacological effects of the main phytocannabinoids: a narrative review. In Cannabinoids and neuropsychiatric disorders. Cham: Springer. doi:10.1007/978-3-030-57369-0_3 -
NLM
Santos RG dos, Hallak JEC, Crippa JA de S. Neuropharmacological effects of the main phytocannabinoids: a narrative review [Internet]. In: Cannabinoids and neuropsychiatric disorders. Cham: Springer; 2020. [citado 2025 abr. 28 ] Available from: https://doi.org/10.1007/978-3-030-57369-0_3 -
Vancouver
Santos RG dos, Hallak JEC, Crippa JA de S. Neuropharmacological effects of the main phytocannabinoids: a narrative review [Internet]. In: Cannabinoids and neuropsychiatric disorders. Cham: Springer; 2020. [citado 2025 abr. 28 ] Available from: https://doi.org/10.1007/978-3-030-57369-0_3 - O uso do canabidiol (CBD) no tratamento da doença de Parkinson e suas comorbidades
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Cannabidiol for the treatment of drug use disorders
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
- Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies
- Natural hallucinogens in mental health [Editorial]
Informações sobre o DOI: 10.1007/978-3-030-57369-0_3 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003209083.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
